JUPITER NEUROSCIENCES, INC. Repayments of Convertible Debt
JUPITER NEUROSCIENCES, INC. (JUNS) reported Repayments of Convertible Debt of $405.95 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. repayments of convertible debt for fiscal 2024 was $150.00K.
| Period end | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 12 month |
|---|---|---|
| 2026-06-30 | $405.95K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $150.00K 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |